The results of selective use of radioactive iodine on survival and on recurrence in the management of papillary thyroid cancer, based on Memorial Sloan-Kettering …
Background: The American Thyroid Association guidelines recommend the routine use of
radioactive iodine for remnant ablation (RRA) in all T3 or greater primary tumors, and …
radioactive iodine for remnant ablation (RRA) in all T3 or greater primary tumors, and …
The results of selective use of radioactive iodine on survival and on recurrence in the management of papillary thyroid cancer, based on Memorial Sloan-Kettering …
IJ Nixon, I Ganly, SG Patel… - … : official journal of …, 2013 - pubmed.ncbi.nlm.nih.gov
Background The American Thyroid Association guidelines recommend the routine use of
radioactive iodine for remnant ablation (RRA) in all T3 or greater primary tumors, and …
radioactive iodine for remnant ablation (RRA) in all T3 or greater primary tumors, and …
The results of selective use of radioactive iodine on survival and on recurrence in the management of papillary thyroid cancer, based on memorial sloan-kettering …
IJ Nixon, I Ganly, SG Patel, FL Palmer… - Thyroid Journal …, 2013 - research.ed.ac.uk
Background: The American Thyroid Association guidelines recommend the routine use of
radioactive iodine for remnant ablation (RRA) in all T3 or greater primary tumors, and …
radioactive iodine for remnant ablation (RRA) in all T3 or greater primary tumors, and …
The Results of Selective Use of Radioactive Iodine on Survival and on Recurrence in the Management of Papillary Thyroid Cancer, Based on Memorial Sloan …
IJ Nixon, I Ganly, SG Patel, FL Palmer… - …, 2013 - search.ebscohost.com
Abstract Background: The American Thyroid Association guidelines recommend the routine
use of radioactive iodine for remnant ablation (RRA) in all T3 or greater primary tumors, and …
use of radioactive iodine for remnant ablation (RRA) in all T3 or greater primary tumors, and …
The results of selective use of radioactive iodine on survival and on recurrence in the management of papillary thyroid cancer, based on Memorial Sloan-Kettering …
IJ Nixon, I Ganly, SG Patel, FL Palmer… - … : Official Journal of the …, 2013 - europepmc.org
Background The American Thyroid Association guidelines recommend the routine use of
radioactive iodine for remnant ablation (RRA) in all T3 or greater primary tumors, and …
radioactive iodine for remnant ablation (RRA) in all T3 or greater primary tumors, and …
[PDF][PDF] The Results of Selective Use of Radioactive Iodine on Survival and on Recurrence in the Management of Papillary Thyroid Cancer
IJ Nixon, I Ganly, SG Patel, FL Palmer… - … outcomes for patients …, 2013 - pure.uva.nl
Background: The American Thyroid Association guidelines recommend the routine use of
radioactive iodine for remnant ablation (RRA) in all T3 or greater primary tumors, and …
radioactive iodine for remnant ablation (RRA) in all T3 or greater primary tumors, and …
[PDF][PDF] The Results of Selective Use of Radioactive Iodine on Survival and on Recurrence in the Management of Papillary Thyroid Cancer
IJ Nixon, I Ganly, SG Patel, FL Palmer… - … outcomes for patients …, 2013 - dare.uva.nl
Background: The American Thyroid Association guidelines recommend the routine use of
radioactive iodine for remnant ablation (RRA) in all T3 or greater primary tumors, and …
radioactive iodine for remnant ablation (RRA) in all T3 or greater primary tumors, and …